Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Eur J Neurol ; 20(4): 704-7, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23216586

ABSTRACT

BACKGROUND AND PURPOSE: Sensory tricks are sensory, often but not exclusively tactile, stimuli usually in the body part affected by the movement disorder that produce a meaningful alleviation of dystonia. The frequency and clinical features of sensory tricks in different types of dystonia are poorly studied in the literature. There is no information regarding the presence of a similar phenomenon in HFS. METHODS: We enrolled consecutive patients who had the diagnosis of HFS (26) or the following types of dystonia: cervical dystonia (CD; 21); blepharospasm (BS; 20); and writer's cramp (WC; 10). Patients underwent a structured interview to assess the following items related to sensory trick: presence, type and effectiveness. Statistical analysis used the Verisimilitude Reason test and the significance level was set at 5%. RESULTS: Sensory trick was more frequent in the CD group (81%) when compared with HFS (38.5%; P=0.004) and WC (20%; P=0.001), but there was no statistical difference from the frequency in BS patients (55%; P=0.078). The most common sensory tricks were facial massage (60%) in HFS; to touch the head with the hands (35.3% in CD); to touch the upper eyelid with the index finger and thumb (81.8%) in BS; and to touch the hand with the contralateral hand (100%) in WC. CONCLUSIONS: Sensory tricks are common in all types of focal dystonia herein studied, although they are more frequent in CD. Patients with HFS also often display improvement of the movement disorder with tactile stimulation.


Subject(s)
Dystonic Disorders/complications , Hemifacial Spasm/complications , Sensation Disorders/etiology , Aged , Blepharospasm/complications , Female , Humans , Likelihood Functions , Male , Middle Aged , Surveys and Questionnaires , Torticollis/complications
3.
Arq. neuropsiquiatr ; 69(2b): 292-296, 2011. ilus, tab
Article in English | LILACS | ID: lil-588086

ABSTRACT

Machado-Joseph disease, or spinocerebellar ataxia type 3(MJD/SCA3), is the most frequent late onset spinocerebellar ataxia and results from a CAG repeat expansion in the ataxin-3 gene. Previous studies have found correlation between atrophy of cerebellum and brainstem with age and CAG repeats, although no such correlation has been found with disease duration and clinical manifestations. In this study we test the hypothesis that atrophy of cerebellum and brainstem in MJD/SCA3 is related to clinical severity, disease duration and CAG repeat length as well as to other variables such as age and ICARS (International Cooperative Ataxia Rating Scale). Whole brain high resolution MRI and volumetric measurement with cranial volume normalization were obtained from 15 MJD/SCA3 patients and 15 normal, age and sex-matchedcontrols. We applied ICARS and compared the score with volumes and CAG number, disease duration and age. We found significant correlation of both brain stem and cerebellar atrophy with CAG repeat length, age, disease duration and degree of disability. The Spearman rank correlation was stronger with volumetric reduction of the cerebellum than with brain stem. Our data allow us to conclude that volumetric analysis might reveal progressive degeneration after disease onset, which in turn is linked to both age and number of CAG repeat expansions in SCA 3.


Doença de Machado-Joseph, ou ataxia espinocerebelar tipo 3 (MJD/SCA3) é ataxia espinocerebelar de início tardio mais frequente e resulta de uma expansão da repetição CAG no gene da ataxina-3. Estudos precedentes encontraram correlação entre a atrofia do cerebelo e do tronco cerebral com a idade e número de expansões CAG. Tais correlações não foram encontradas em relação ao tempo de doença ou manifestações clínicas. Neste estudo testamos a hipótese de que a atrofia do cerebelo e do tronco encefálico em MJD/SCA3 está relacionada à gravidade clínica, duração da doença e número de repetições CAG, bem como com outras variáveis como a idade e a ICARS (escala cooperativa internacional de avaliação de ataxias). Foram realizados estudos de imagem pela ressonância magnética de alta resolução e volumetria com normalização de volume craniano de 15 pacientes portadores de MJD/SCA3 e 15 controles pareados por idade e sexo. Nós aplicamos a ICARS e correlacionamos com o escore de volumes e número de CAG, duração da doença e idade. Encontramos correlação significativa entre atrofia de tronco cerebral e cerebelo com duração da doença, repetição CAG, idade e grau de acometimento da doença. O índice de correlação de Spearman foi maior em relação à atrofia de cerebelo do que à atrofia de tronco. Nossos dados permitem concluir que a análise volumétrica pode revelar degeneração progressiva após o início da doença que, por sua vez, está ligada à idade e número de expansões CAG em SCA 3.


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Brain Stem/pathology , Cerebellum/pathology , Machado-Joseph Disease/pathology , Atrophy/pathology , Case-Control Studies , Magnetic Resonance Imaging , Severity of Illness Index
4.
Eur J Neurol ; 7(5): 467-71, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11054129

ABSTRACT

We studied the clinical features, laboratory investigation, management and natural history of a cohort of patients with Juvenile Parkinsonism (JP), seen at a tertiary referral centre. JP was defined as Parkinsonism with onset at age 20 years or less. Six patients (five male, one female) entered the study. The mean age at onset of Parkinsonism was 12.5 years (range 7-19) and the mean follow-up time was 49.3 months (range 40-57). Bradykinesia, rigidity, and postural instability were observed in all patients and five subjects had tremor. Dystonia was present in four subjects. Other clinical features were dementia (five subjects), supranuclear ophthalmoparesis (five subjects), seizures (three subjects), multifocal myoclonus (one subject), decreased deep reflexes (one subject), pyramidal signs (one subject). Family history of Parkinson's disease (PD) was positive in one subject. Work-up for Wilson's disease was negative in all patients. Neuroimaging studies showed cortical atrophy in two subjects and mild brainstem atrophy in two others. Sea-blue histiocytes were found in one subject. L-dopa improved the Parkinsonism in all subjects but four rapidly developed fluctuations and dyskinesias, requiring, in one, stereotaxic surgery. After a mean disease duration of 6.5 years, five subjects require assistance for performance of all daily activities. JP is a heterogeneous clinical entity. In the majority of patients, no underlying cause is identified. The unusual clinical features suggest most subjects have a CNS degenerative disease distinct from PD. There is, however, evidence suggesting that PD may rarely cause JP. Gangliosidosis is another cause of L-dopa-responsive JP. Regardless of the cause, in the present study JP displays an aggressive and rapidly progressive course in most patients.


Subject(s)
Parkinsonian Disorders/diagnosis , Adolescent , Adult , Age of Onset , Child , Cohort Studies , Disease Progression , Female , Humans , Male , Parkinsonian Disorders/drug therapy , Parkinsonian Disorders/surgery , Treatment Outcome
5.
Arq Neuropsiquiatr ; 56(2): 171-5, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9698723

ABSTRACT

OBJECTIVE: The aim of the present study is to investigate whether there are geographic differences in the etiology of parkinsonism (PA). BACKGROUND: 72% of patients with PA evaluated at movement disorders clinics in the Northern Hemisphere are diagnosed with Parkinson's disease (PD). Data regarding other regions are not available. METHODS: We reviewed the charts of all patients with PA seen at the Federal University of Minas Gerais Movement Disorders Clinic from July 1993 through October 1995. PA was diagnosed by the presence of at least two of the following: rest tremor, bradykinesia, rigidity, and postural instability. The different etiologies were diagnosed based on standard clinical criteria. RESULTS: During the period of the study, PA was recognized in 338 subjects. The following clinical diagnoses were made: PD (68.9%), drug-induced PA (DIP) (13.3%), vascular PA (4.7%), Progressive supranuclear palsy (PSP) (2%), multiple system atrophy (MSA) (1.8%), others (9.7%). Cinnarizine, haloperidol and flunarizine were the commonest drugs related to DIP. CONCLUSIONS: Similarly to other studies, PD accounts for about 70% of PA patients. However, there are differences between our results and previous series. DIP is much more common in the present series. This may be accounted for a more liberal use of antidopaminergic drugs in our environment, especially Calcium channel blockers. The lower frequency of MSA and PSP in our study may reflect a short follow-up, since many patients initially diagnosed with PD later are found to have Parkinson-plus syndromes.


Subject(s)
Parkinson Disease, Secondary/etiology , Aged , Anti-Dyskinesia Agents/adverse effects , Brazil , Calcium Channel Blockers/adverse effects , Cinnarizine/adverse effects , Female , Flunarizine/adverse effects , Haloperidol/adverse effects , Histamine H1 Antagonists/adverse effects , Humans , Male , Middle Aged , Parkinson Disease/complications , Parkinson Disease/diagnosis , Parkinson Disease, Secondary/chemically induced , Parkinson Disease, Secondary/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...